跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 603 条关于
“B2M”
全部
603
临床试验
288
药物
239
机构
2
资讯
74
28天前
Blood Protein Biomarkers B2M and Cystatin C Predict Future Disability in Very Old Adults
去年
Applied StemCell Launches Hypoimmunogenic hiPSC Products to Advance Allogeneic Cell Therapy Development
10个月前
Caribou Biosciences to Present First Clinical Data from Dual Allogeneic CAR-T Programs in Lymphoma and Multiple Myeloma
去年
CARsgen's THANK-u Plus Platform Drives Advancements in Allogeneic CAR-T Therapy for Hematologic Malignancies
去年
Pembrolizumab-Vorinostat Combination Shows Promise in Recurrent Squamous Cell Carcinoma
去年
$22 Million Boost for Australian Cancer Clinical Trials to Enhance Research and Access
去年
Faron Pharmaceuticals Secures €12M to Advance Promising MDS Treatment Bexmarilimab
去年
Pathos AI Secures $62M Series C Funding to Advance AI-Powered Drug Development
10个月前
Evidium Secures $22M Series A to Advance Transparent Healthcare AI Platform
去年
Kivu Biosciences Secures $92M to Advance 'Kinder, Gentler' Antibody-Drug Conjugates
第 1 页,共 8 页
上一页
下一页